Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 37,496 | 13,868 | 24,210 | 52,038 | 10,620 |
| General And Administrative Expense | 37,496 | 13,868 | 24,210 | 52,038 | 10,620 |
| Other Operating Expenses | -- | -- | -- | 1.00 | 229.00 |
| Operating Expense | 37,496 | 13,868 | 24,210 | 52,039 | 10,849 |
| Operating Income | -37,496 | -13,868 | -24,210 | -52,039 | -10,849 |
| EBIT | -37,496 | -13,868 | -24,210 | -52,039 | -10,849 |
| Other Income Expense | -4.00 | -7.00 | 250,262 | -20,662 | 8,145 |
| Other Non Operating Income Expenses | -- | -5.00 | 250,054 | -- | -- |
| Special Income Charges | 4.00 | 0.00 | 0.00 | -1,221 | 1.00 |
| Write Off | -- | -- | -- | -- | 0.00 |
| Gain On Sale Of Security | -8.00 | -2.00 | 208.00 | -19,441 | 8,144 |
| Pretax Income | -37,500 | -13,875 | 226,052 | -72,701 | -2,704 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 31.20 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -37,500 | -13,875 | 226,052 | -72,701 | -2,704 |
| Net Income From Continuing Operation Net Minority Interest | -37,500 | -13,875 | 226,052 | -72,701 | -2,704 |
| Net Income Including Noncontrolling Interests | -37,500 | -13,875 | 226,052 | -72,701 | -2,704 |
| Net Income Common Stockholders | -37,500 | -13,875 | 226,052 | -72,701 | -2,704 |
| Net Income | -37,500 | -13,875 | 226,052 | -72,701 | -2,704 |
| EBITDA | -37,496 | -13,868 | -24,210 | -52,039 | -10,849 |
| Normalized EBITDA | -37,492 | -13,866 | -24,418 | -31,377 | -18,994 |
| Basic EPS | 0.00 | 0.00 | 0.01 | -- | 0.00 |
| Diluted EPS | 0.00 | 0.00 | 0.01 | -- | 0.00 |
| Basic Average Shares | 23.6M | 22.1M | 22.0M | -- | 20.5M |
| Diluted Average Shares | 23.6M | 22.1M | 22.0M | -- | 20.5M |
| Total Unusual Items | -4.00 | -2.00 | 208.00 | -20,662 | 8,145 |
| Total Unusual Items Excluding Goodwill | -4.00 | -2.00 | 208.00 | -20,662 | 8,145 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 |
| Normalized Income | -37,496 | -13,873 | 225,875 | -52,039 | -10,849 |
| Diluted NI Availto Com Stockholders | -37,500 | -13,875 | 226,052 | -72,701 | -2,704 |
| Gain On Sale Of Ppe | 0.00 | 0.00 | -- | -- | 0.00 |
| Impairment Of Capital Assets | 0.00 | 0.00 | 0.00 | 612.00 | -1.00 |
| Net Income Continuous Operations | -37,500 | -13,875 | 226,052 | -72,701 | -2,704 |
| Other Gand A | 37,496 | 13,868 | 24,210 | 52,038 | 10,620 |
| Other Special Charges | -4.00 | -- | -- | 609.00 | 96.00 |
| Total Expenses | 37,496 | 13,868 | 24,210 | 52,039 | 10,849 |
| Total Operating Income As Reported | -37,496 | -13,868 | -24,210 | -52,648 | -10,849 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 21,380 | 3,201 | 5,875 | 29,397 | 4,678 |
| Cash Cash Equivalents And Short Term Investments | 21,380 | 3,201 | 5,875 | 29,397 | 4,678 |
| Cash Financial | 21,380 | 3,201 | 5,875 | 29,397 | 4,678 |
| Receivables | 2,496 | 265.00 | 224.00 | 337.00 | 0.00 |
| Prepaid Assets | 1,498 | -- | -- | -- | -- |
| Current Assets | 25,374 | 3,466 | 6,099 | 29,734 | 4,678 |
| Net PPE | 18,599 | 16,318 | 17,195 | 17,210 | 16,753 |
| Total Non Current Assets | 18,599 | 16,318 | 17,195 | 17,210 | 16,753 |
| Total Assets | 43,973 | 19,784 | 23,294 | 46,944 | 21,431 |
| Accounts Payable | 114,106 | 127,199 | 129,595 | 680,474 | 145,208 |
| Payables | 408,581 | 431,217 | 426,260 | 682,664 | 669,914 |
| Payables And Accrued Expenses | 408,581 | 431,217 | 426,260 | 682,664 | 669,914 |
| Current Liabilities | 408,581 | 431,217 | 426,260 | 682,664 | 669,914 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 408,581 | 431,217 | 426,260 | 682,664 | 669,914 |
| Common Stock | 60.2M | 60.1M | 60.1M | 60.1M | 60.0M |
| Capital Stock | 60.2M | 60.1M | 60.1M | 60.1M | 60.0M |
| Additional Paid In Capital | 8.7M | 8.7M | 8.7M | 8.7M | 8.7M |
| Retained Earnings | -68.6M | -68.6M | -68.6M | -68.8M | -68.7M |
| Gains Losses Not Affecting Retained Earnings | -840,461 | -840,806 | -839,930 | -839,914 | -840,985 |
| Other Equity Adjustments | -840,461 | -840,806 | -839,930 | -839,914 | -840,985 |
| Common Stock Equity | -364,608 | -411,433 | -402,966 | -635,720 | -648,483 |
| Stockholders Equity | -364,608 | -411,433 | -402,966 | -635,720 | -648,483 |
| Total Equity Gross Minority Interest | -364,608 | -411,433 | -402,966 | -635,720 | -648,483 |
| Total Capitalization | -364,608 | -411,433 | -402,966 | -635,720 | -648,483 |
| Net Tangible Assets | -364,608 | -411,433 | -402,966 | -635,720 | -648,483 |
| Tangible Book Value | -364,608 | -411,433 | -402,966 | -635,720 | -648,483 |
| Working Capital | -383,207 | -427,751 | -420,161 | -652,930 | -665,236 |
| Invested Capital | -364,608 | -411,433 | -402,966 | -635,720 | -648,483 |
| Share Issued | 22.9M | 22.1M | 22.0M | 22.0M | 20.5M |
| Ordinary Shares Number | 22.9M | 22.1M | 22.0M | 22.0M | 20.5M |
| Dueto Related Parties Current | 1,050 | 10,593 | 3,240 | 2,190 | 20,281 |
| Other Equity Interest | 176,244 | 195,355 | 195,355 | 195,355 | 195,355 |
| Other Payable | 293,425 | 293,425 | 293,425 | -- | 504,425 |
| Taxes Receivable | 2,496 | 265.00 | 224.00 | 337.00 | 0.00 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -63,021 | -4,474 | -23,522 | -46,495 | -16,414 |
| Cash Flow From Continuing Operating Activities | -63,021 | -4,474 | -23,522 | -46,495 | -16,414 |
| Stock Based Compensation | 2,780 | 4,484 | 6,718 | 11,860 | 1,814 |
| Change In Working Capital | -28,297 | 4,912 | -6,238 | 14,346 | -15,524 |
| Change In Receivables | -1,233 | -41.00 | 113.00 | -336.00 | 0.00 |
| Change In Payables And Accrued Expense | -24,568 | 4,953 | -6,351 | 14,682 | -15,524 |
| Change In Payable | -24,568 | 4,953 | -6,351 | 14,682 | -15,524 |
| Other Non Cash Items | -4.00 | 5.00 | -250,054 | -- | -- |
| Net PPE Purchase And Sale | -- | -- | -- | -1,319 | 0.00 |
| Investing Cash Flow | -- | -- | -- | -1,319 | 0.00 |
| Cash Flow From Continuing Investing Activities | -- | -- | -- | -1,319 | 0.00 |
| Issuance Of Capital Stock | -- | -- | -- | 72,533 | -- |
| Net Common Stock Issuance | -- | -- | -- | 72,533 | -- |
| Financing Cash Flow | 81,200 | -- | -- | 72,533 | 0.00 |
| Cash Flow From Continuing Financing Activities | 81,200 | -- | -- | 72,533 | 0.00 |
| Changes In Cash | 18,179 | -2,674 | -23,522 | 24,719 | -16,414 |
| Beginning Cash Position | 3,201 | 5,875 | 29,397 | 4,678 | 21,092 |
| End Cash Position | 21,380 | 3,201 | 5,875 | 29,397 | 4,678 |
| Free Cash Flow | -63,021 | -4,474 | -23,522 | -47,814 | -16,414 |
| Change In Account Payable | -15,025 | -2,400 | -7,401 | 32,773 | -12,405 |
| Common Stock Issuance | -- | -- | -- | 72,533 | -- |
| Net Income From Continuing Operations | -37,500 | -13,875 | 226,052 | -72,701 | -2,704 |
| Proceeds From Stock Option Exercised | 81,200 | -- | -- | -- | 0.00 |